Mefoglip Tablet

About Mefoglip 2.5 mg + 250 mg Tablet

Incepta Pharmaceuticals Ltd. manufactures Mefoglip, a tablet combining Glipizide and Metformin Hydrochloride. It is a prescription medicine for type 2 diabetes, available in a strength of 2.5 mg + 250 mg.

There are 6 brands of Glipizide + Metformin Hydrochloride listed in Bangladesh. 1 of them has a lower unit price than Mefoglip.

What is Mefoglip 2.5 mg + 250 mg Tablet?

Mefoglip is a tablet from Incepta Pharmaceuticals Ltd. that combines two oral diabetes medicines, Glipizide and Metformin Hydrochloride, in a strength of 2.5 mg + 250 mg. It belongs to the combination oral hypoglycemic preparations class. It is used for type 2 diabetes when diet and exercise alone do not control blood sugar, or as second-line therapy. The doctor determines the appropriate dose and course for each patient. The tablet is taken with meals, and the dose is adjusted gradually. Regular monitoring and medical follow-up are important while using this medicine.

Uses of Mefoglip

Mefoglip is used to improve blood sugar control in adults with type 2 diabetes. It is prescribed when diet and exercise alone are not enough, or as a second-line treatment when other initial therapy has not worked. It helps lower both fasting and post-meal blood sugar levels. The doctor decides if this combination is suitable for a particular patient.

How to use Mefoglip

Mefoglip is taken by mouth, usually once or twice daily with meals. The doctor starts with a low dose and increases it gradually based on blood sugar response. Swallow the tablet with water. Do not change the dose or stop taking it without medical advice. Follow the doctor's instructions about meal timing and monitoring.

Side effects of Mefoglip

Common side effects include low blood sugar (hypoglycemia), diarrhea, nausea, vomiting, abdominal pain, headache, and muscle or joint pain. Low blood sugar may cause shakiness, sweating, or confusion. If you experience severe or persistent side effects, contact your doctor. Do not ignore symptoms that worry you.

Safety and precautions

Mefoglip is not for everyone. It should not be used in people with kidney or liver problems, diabetic coma, ketoacidosis, heart failure, dehydration, or alcohol dependence. It is not recommended during pregnancy or breastfeeding. Older adults and those with reduced kidney function need careful dose adjustment. Tell your doctor about all medicines you take, including alcohol, as interactions can occur. Your doctor will decide if this medicine is safe for you.

Frequently asked questions

What is the price of Mefoglip?

The listed price is ৳ 1.9.

What does the generic name mean?

The generic name Glipizide + Metformin Hydrochloride shows the two active ingredients. Glipizide is a sulfonylurea that helps the pancreas release more insulin, while Metformin Hydrochloride is a biguanide that lowers sugar production in the liver and improves insulin use.

What is Mefoglip used for and what kind of medicine is it?

Mefoglip is a combination oral hypoglycemic preparation for type 2 diabetes. It helps control blood sugar when diet and exercise alone are not enough. It is a prescription medicine, and the doctor decides if it is appropriate for you.

What do the dosage form and strength mean?

Mefoglip comes as a tablet, which is taken by mouth. The strength 2.5 mg + 250 mg means each tablet contains 2.5 mg of Glipizide and 250 mg of Metformin Hydrochloride. The doctor will determine the dose and course that are right for you.

Indications

Glipizide & Metformin is indicated as initial therapy, as an adjunct to diet and exercise, to improve glycemic control in patients with type 2 diabetes whose hyperglycemia cannot be satisfactorily managed with diet and exercise alone and as second-line therapy when diet, exercise, and initial treatment ... Read moreGlipizide & Metformin is indicated as initial therapy, as an adjunct to diet and exercise, to improve glycemic control in patients with type 2 diabetes whose hyperglycemia cannot be satisfactorily managed with diet and exercise alone and as second-line therapy when diet, exercise, and initial treatment with a Sulfonylurea or Metformin do not result in adequate glycemic control in patients with type 2 diabetes

Pharmacology

Metformin is a biguanide antihyperglycemic agent, which improves glucose tolerance in patients with type 2 diabetes, lowering both basal and postprandial plasma glucose. Its pharmacological mechanisms of action are different from other classes of oral antihyperglycemic agents. Metformin decreases hepatic glucose production, decreases intestinal absorption of glucose, and improves insulin sensitivity by increasing peripheral glucose uptake and utilization. Unlike sulfonylurea, metformin does not produce hypoglycemia in either patient with type 2 diabetes or normal subjects and does not cause hyperinsulinemia.

Glipizide is a sulfonylurea which appears to lower blood glucose by stimulating the release of insulin from the pancreas, an effect dependent upon functioning beta cells in the pancreatic islets. Extrapancreatic effects may play a part in the mechanism of action of oral sulfonylurea hypoglycemic drugs.

Dosage & Administration

Glipizide & Metformin should be given once or twice daily with meals and should be initiated at a low dose, with gradual dose escalation.

Glipizide & Metformin as Initial Therapy: The recommended starting dose is 250 mg/2.5 mg once a day with meal.

Glipizide & Metformin as Second-Line Therapy: The recommended starting dose is 500 mg/2.5 mg or 500 mg/5 mg twice daily with the morning and evening meals. The maximum recommended daily dose is 2000 mg Metformin/20 mg Glipizide.

Interaction

Cimetidine reduces the renal clearance of Metformin. Alcohol potentiates the antihyperglycemic & hyperlactataemic effect of Metformin. It may enhance the effects of anti-coagulants. Such patients receiving the two drugs may need adjustment of the anti-coagulant dosage. Nifedipine appears to enhance the absorption of Metformin but Metformin has minimal effects on Nifedipine. The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents, some azoles, and other drugs that are highly protein bound, salicylates, sulfonamides, chloramphenicol, probenecid, coumarins, monoamine oxidase inhibitors, and beta adrenergic blocking agents.

Contraindications

Hypersensitivity to the drug, renal impairment, diabetic coma and ketoacidosis, chronic renal diseases, congestive heart failure, trauma, dehydration, alcohol dependence, pregnancy, breast-feeding etc.

Side Effects

The most common side effects of Glipizide & Metformin are hypoglycemia,
diarrhea, nausea/vomiting, abdominal pain, headache, musculoskeletal pain etc.

Pregnancy & Lactation

Contraindicated during Pregnancy & Lactation

Precautions & Warnings

Metformin is known to be substantially excreted by the kidney, and the risk of Metformin accumulation and lactic acidosis is increased with the degree of impairment of renal function. Thus, patients with serum creatinine levels above the upper limit of normal should not receive Metformin. In patients with advanced age, Metformin should be carefully titrated to establish minimum dose for adequate glycemic control, because aging is associated with reduced renal function. Metformin therapy should be temporarily suspended for any surgical procedure and should not be restarted until the patient’s oral intake has resumed and renal function has been evaluated as normal. During concomitant therapy with sulfonylurea, blood glucose should be monitored. Metformin & insulin therapy should be carried out in hospital until the correct ratio of the two drugs has been established. The metabolism and excretion of Glipizide may be slowed in patients with impaired renal and/or hepatic function. If hypoglycemia should occur in such patients, it may be prolonged and appropriate management should be instituted.

Storage Conditions

Store below 25ºC in a cool and dry place.

Alternative brands of Glipizide + Metformin Hydrochloride

Other brands with the same generic name, cheapest first.

Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.